SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001578563-22-000006
Filing Date
2022-03-10
Accepted
2022-03-10 17:50:14
Documents
1
Period of Report
2022-03-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6412
  Complete submission text file 0001578563-22-000006.txt   7902
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CERECOR INC. 400 E. PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Sullivan Christopher Ryan (Reporting) CIK: 0001810417 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 22730314